Cargando…
Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells
AIMS: Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) have become a promising tool in cardiovascular safety pharmacology. Immaturity of iPS-CMs remains an ongoing concern. We compared electrophysiological and contractile features of cardiac bodies (hiPS-CBs) derived from human-induced...
Autores principales: | Trieschmann, Jan, Haustein, Moritz, Köster, Annette, Hescheler, Jürgen, Brockmeier, Konrad, Bennink, Gerardus, Hannes, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431377/ https://www.ncbi.nlm.nih.gov/pubmed/30956672 http://dx.doi.org/10.1155/2019/6096294 |
Ejemplares similares
-
Excitation-Contraction Coupling in Zebrafish Ventricular Myocardium Is Regulated by Trans-Sarcolemmal Ca(2+) Influx and Sarcoplasmic Reticulum Ca(2+) Release
por: Haustein, Moritz, et al.
Publicado: (2015) -
The Interaction between Adult Cardiac Fibroblasts and Embryonic Stem Cell-Derived Cardiomyocytes Leads to Proarrhythmic Changes in In Vitro Cocultures
por: Trieschmann, Jan, et al.
Publicado: (2016) -
Protein losing enteropathy secondary to a pulmonary artery stent
por: Sreeram, Narayanswami, et al.
Publicado: (2012) -
Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations
por: Hamad, Sarkawt, et al.
Publicado: (2019) -
High-efficient serum-free differentiation of endothelial cells from human iPS cells
por: Hamad, Sarkawt, et al.
Publicado: (2022)